My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 137

    1.

    Diacylglycerol oil for the metabolic syndrome.

    Yanai H, Tomono Y, Ito K, Furutani N, Yoshida H, Tada N.

    Nutr J. 2007 Dec 11;6:43. Review.PMID: 18072966 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    [Therapeutic application of diacylglycerol oil for the metabolic syndrome]

    Yanai H, Tomono Y, Yoshida H, Tada N.

    Rinsho Byori. 2010 Jan;58(1):39-44. Japanese. PMID: 20169943 [PubMed - in process]Related articles

    3.

    Metabolism of diacylglycerol in humans.

    Takase H.

    Asia Pac J Clin Nutr. 2007;16 Suppl 1:398-403. Review.PMID: 17392138 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effects of diacylglycerol on glucose, lipid metabolism, and plasma serotonin levels in lean Japanese.

    Yanai H, Yoshida H, Tomono Y, Hirowatari Y, Kurosawa H, Matsumoto A, Tada N.

    Obesity (Silver Spring). 2008 Jan;16(1):47-51.PMID: 18223611 [PubMed - indexed for MEDLINE]Related articles

    5.

    The effects of diacylglycerol oil on fat oxidation and energy expenditure in humans and animals.

    Hibi M, Takase H, Meguro S, Tokimitsu I.

    Biofactors. 2009 Mar-Apr;35(2):175-7. Review.PMID: 19449445 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effects of diacylglycerol ingestion on postprandial hyperlipidemia in diabetes.

    Tada N, Shoji K, Takeshita M, Watanabe H, Yoshida H, Hase T, Matsuo N, Tokimitsu I.

    Clin Chim Acta. 2005 Mar;353(1-2):87-94.PMID: 15698594 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of diacylglycerol oil on adiposity in obese children: initial communication.

    Matsuyama T, Shoji K, Watanabe H, Shimizu M, Saotome Y, Nagao T, Matsuo N, Hase T, Tokimitsu I, Nakaya N.

    J Pediatr Endocrinol Metab. 2006 Jun;19(6):795-804.PMID: 16886587 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effects of a 1,3-diacylglycerol oil-enriched diet on postprandial lipemia in people with insulin resistance.

    Reyes G, Yasunaga K, Rothenstein E, Karmally W, Ramakrishnan R, Holleran S, Ginsberg HN.

    J Lipid Res. 2008 Mar;49(3):670-8. Epub 2007 Dec 18.PMID: 18089891 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Greater fat oxidation with diacylglycerol oil consumption for 14 days compared with triacylglycerol oil consumption in overweight men and women.

    Hibi M, Takase H, Yasunaga K, Yamaguchi T, Shiiba D, Saito S, Yokoyama R, Kudo N, Katsuragi Y, Meguro S, Shimizu A, Tokimitsu I.

    Int J Obes (Lond). 2008 Dec;32(12):1841-7. Epub 2008 Oct 21.PMID: 18936764 [PubMed - indexed for MEDLINE]Related articles

    10.

    Inflammation, obesity, and fatty acid metabolism: influence of n-3 polyunsaturated fatty acids on factors contributing to metabolic syndrome.

    Robinson LE, Buchholz AC, Mazurak VC.

    Appl Physiol Nutr Metab. 2007 Dec;32(6):1008-24. Review.PMID: 18059573 [PubMed - indexed for MEDLINE]Related articles

    11.

    The effect of statin alone or in combination with ezetimibe on postprandial lipoprotein composition in obese metabolic syndrome patients.

    Hajer GR, Dallinga-Thie GM, van Vark-van der Zee LC, Visseren FL.

    Atherosclerosis. 2009 Jan;202(1):216-24. Epub 2008 Apr 26.PMID: 18533158 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effects of dietary diacylglycerol on the energy metabolism.

    Kimura S, Tsuchiya H, Inage H, Meguro S, Matsuo N, Tokimitsu I.

    Int J Vitam Nutr Res. 2006 Mar;76(2):75-9.PMID: 16941418 [PubMed - indexed for MEDLINE]Related articles

    13.

    Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trial.

    Hajer GR, Dallinga-Thie GM, van Vark-van der Zee LC, Olijhoek JK, Visseren FL.

    Clin Endocrinol (Oxf). 2008 Dec;69(6):870-7. Epub 2008 Apr 3.PMID: 18394022 [PubMed - indexed for MEDLINE]Related articles

    14.

    Size-based distributions of postprandial lipoproteins in lymph and serum after oral administration of triacylglycerol and diacylglycerol oils in rats.

    Saito S, Nakagiri H, Watanabe H, Matsuo N, Tokimitsu I, Okazaki M.

    J Nutr Sci Vitaminol (Tokyo). 2008 Dec;54(6):491-6.PMID: 19155588 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Physiological actions of diacylglycerol outcome.

    Tada N.

    Curr Opin Clin Nutr Metab Care. 2004 Mar;7(2):145-9. Review.PMID: 15075704 [PubMed - indexed for MEDLINE]Related articles

    16.

    A moderate-fat diet for combined hyperlipidemia and metabolic syndrome.

    Knopp RH, Fish B, Dowdy A, Retzlaff B, Walden C, Rusanu I, Paramsothy P.

    Curr Atheroscler Rep. 2006 Nov;8(6):492-500. Review.PMID: 17045076 [PubMed - indexed for MEDLINE]Related articles

    17.

    Preventive effects of Bofutsushosan on obesity and various metabolic disorders.

    Shimada T, Kudo T, Akase T, Aburada M.

    Biol Pharm Bull. 2008 Jul;31(7):1362-7.PMID: 18591775 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Fasting triacylglycerol status, but not polyunsaturated/saturated fatty acid ratio, influences the postprandial response to a series of oral fat tolerance tests.

    Dekker MJ, Wright AJ, Mazurak VC, Marangoni AG, Rush JW, Graham TE, Robinson LE.

    J Nutr Biochem. 2009 Sep;20(9):694-704. Epub 2008 Oct 1.PMID: 18829281 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Postprandial metabolic disorder]

    Mori Y.

    Nippon Rinsho. 2008 Jun;66(6):1219-29. Review. Japanese. PMID: 18540374 [PubMed - indexed for MEDLINE]Related articles

    20.

    Diacylglycerol on lipid metabolism.

    Tada N, Yoshida H.

    Curr Opin Lipidol. 2003 Feb;14(1):29-33. Review.PMID: 12544658 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk